Absynth Biologics Ltd.
Vaccines and antibiotics against resistant infections
This article was originally published in Start Up
Executive Summary
Absynth Biologics Ltd. aims to harness patients’ own immune systems in the fight to prevent and treat bacterial infections; its platform identifies proteins on the cell membranes of bacteria that are essential for their survival, and are highly conserved. Combinations of these proteins, with additive or synergistic potential, are then used to create vaccines and antibodies that may inhibit bacterial activity, as well as engage the immune system to attack and eliminate the infection.